[LGND] QoQ Quarter Result on 31-Dec-2014 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
23-Feb-2015
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 451.17%
YoY- 277.47%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 17,701 18,418 14,602 22,998 14,973 10,608 15,958 7.14%
PBT 7,284 22,292 -74 7,012 901 1,241 2,150 125.40%
Tax -217,255 265 15 279 124 -47 53 -
NP 199,165 23,564 754 7,055 1,280 1,592 2,097 1975.90%
Tax Rate 2,982.63% -1.19% - -3.98% -13.76% 3.79% -2.47% -
Total Cost -181,464 -5,146 13,848 15,943 13,693 9,016 13,861 -
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 1,125.16 127.94 5.16 30.68 8.55 15.01 13.14 1837.47%
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
EPS 10.01 1.19 0.04 0.35 0.06 0.08 0.10 2049.83%
EPS Diluted 9.28 1.11 0.04 0.34 0.06 0.07 0.10 1944.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.